WE ARE THE FIRST HEALTHCARE COMMUNICATIONS AGENCY TO SPECIALIZE IN CELL AND GENE THERAPIES

  2. We combine expertise in cell and gene therapies with a global agency platform and extensive experience in healthcare communications

  2. We have been working exclusively with pharmaceutical and biotechnology companies developing and commercializing cell and gene therapies for over 5 years

  2. We are experienced in supporting companies with products in early-phase clinical development, as well as those commercializing cell and gene therapies for the first time

Answering your key questions

  1. Communicate highly complex science

  2. Strategy, insights and influence

  3. Build and facilitate collaborations

  4. Design and digital innovation

  5. Integrated programme design

What we do

We have worked with multiple pharmaceutical and biotechnology companies, ranging from small start-ups to global organizations

We have experience in working across >35 rare diseases, including 11 cell and gene therapies

Divider Line

We use a range of tactics to extend the reach of data and engage multiple audiences

Ad Board White

Advisory boards
Clinical Trial Ed White

Clinical trial education
Congresses White

Congresses, symposia, and standalone meetings
Elearning White

eLearning materials
Internal Training White

Internal training programmes
Marketaccess A White

Market access
Mech Of Action White

Mechanism of action videos and other science education
Patient Ed White

Patient education materials
Programme Plan White

Programme planning and tactical execution
Publications White

Publications
Sci Messaging White

Scientific messaging and communication platforms
Stakeholder Map White

Stakeholder mapping and profiling
Strategy White

Strategy and commercialization support

Our Team

Divider Line

Seques® is part of AMICULUM®, an independent family of 11 specialist branded agencies with over 350 medical communications professionals in 13 worldwide locations.

Our team hold academic qualifications in genetics and many have practical experience of gene editing technologies.

We collaborate with the wider AMICULUM family to provide clients with the optimal team size, expertise and skills tailored for their project.

Get In Touch

Linkedin Find us on LinkedIn
  1. Patricia Jones
    Patricia.Jones@seques.biz +44(0)7825536076
  2. Jenny Szkolar
    Jenny.Szkolar@seques.biz +44(0)7584571759